Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh ( (AU:RMD) ) has provided an announcement.
Resmed Inc has announced an update on its CHESS Depositary Interests (CDIs), indicating a net increase of 278,240 CDIs issued over quoted securities in July 2025. This change is attributed to net transfers between CDIs and common stock, as well as activities related to stock options and employee stock plans. The update reflects the company’s ongoing adjustments in its securities management, which may impact its market positioning and stakeholder interests.
The most recent analyst rating on (AU:RMD) stock is a Buy with a A$41.00 price target. To see the full list of analyst forecasts on Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh stock, see the AU:RMD Stock Forecast page.
More about Resmed Inc CHESS Depositary Interests on a ratio of 10 CDIs per ord.sh
Resmed Inc operates in the healthcare industry, primarily focusing on the development and manufacturing of products for the treatment of sleep apnea and other respiratory conditions. The company is known for its innovative solutions in sleep and respiratory care, serving a global market with a strong presence in both the ASX and NYSE.
Average Trading Volume: 835,018
Technical Sentiment Signal: Buy
Current Market Cap: A$63.16B
Learn more about RMD stock on TipRanks’ Stock Analysis page.